COL17A1 is known to be overexpressed in many malignancies, such as pancreatic adenocarcinoma, and promoting cell multiplication and cell apoptosis inhibition, by activating the NF-κB pathway, may have a role in cancer development and progression [33]. Here, COL17A1 is linked to cancer.